Noise level: Our pick for the best quiet CPAP machine is the Luna G3, but you'll want to make sure that whichever model you ...

ResMed (NYSE:RMD) reported solid financial performance for the quarter ending March 31, 2025, with sales increasing to $1,292 million and net income reaching $365 million year-over-year. The company ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the third quarter of fiscal 2025 were $2.37, up 11.3% year over year.

The Breas Z2 Auto is a good option for travelers who value simplicity. The machine comes with a bunch of accessories right in the box, including a waterless humidifying attachment (called a ...

Q3 2025 Management View CEO Mick Farrell highlighted strong financial performance, with revenue growth, gross margin expansion, and robust free cash flow generation. He attributed this to disciplined ...

While ResMed stands to benefit from structural trends in respiratory and digital health, as well as the launch of its next generation AirSense 11 product in the U.S. later this calendar year ...

A compound annual growth rate (CAGR) of 6.8% is anticipated for the market, which is expected to reach USD 3,829.7 million in 2025 and climb to USD 7,389.6 million by 2035.

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. ResMed beat analysts’ revenue expectations by 1% last quarter ...

ResMed RMD is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release. Analysts are estimating that ResMed ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...